- Home
- FONR vs THTX Comparison
FONR vs THTX Comparison
Compare FONR & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- THTX
- Stock Information
- Founded
- FONR 1978
- THTX 1993
- Country
- FONR United States
- THTX Canada
- Employees
- FONR N/A
- THTX N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- FONR Health Care
- THTX Health Care
- Exchange
- FONR Nasdaq
- THTX Nasdaq
- Market Cap
- FONR 95.7M
- THTX 93.3M
- IPO Year
- FONR 1987
- THTX N/A
- Fundamental
- Price
- FONR $15.22
- THTX $1.72
- Analyst Decision
- FONR
- THTX Hold
- Analyst Count
- FONR 0
- THTX 1
- Target Price
- FONR N/A
- THTX N/A
- AVG Volume (30 Days)
- FONR 9.4K
- THTX 178.5K
- Earning Date
- FONR 02-12-2025
- THTX 02-19-2025
- Dividend Yield
- FONR N/A
- THTX N/A
- EPS Growth
- FONR N/A
- THTX N/A
- EPS
- FONR 1.42
- THTX N/A
- Revenue
- FONR $102,006,089.00
- THTX $84,316,000.00
- Revenue This Year
- FONR N/A
- THTX $5.78
- Revenue Next Year
- FONR N/A
- THTX $2.47
- P/E Ratio
- FONR $10.70
- THTX N/A
- Revenue Growth
- FONR 0.70
- THTX 5.75
- 52 Week Low
- FONR $14.05
- THTX $1.08
- 52 Week High
- FONR $24.05
- THTX $2.18
- Technical
- Relative Strength Index (RSI)
- FONR 47.95
- THTX 50.28
- Support Level
- FONR $15.03
- THTX $1.69
- Resistance Level
- FONR $15.40
- THTX $1.83
- Average True Range (ATR)
- FONR 0.29
- THTX 0.13
- MACD
- FONR 0.03
- THTX -0.04
- Stochastic Oscillator
- FONR 70.41
- THTX 19.30
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.